Key result
Admission repolarization abnormalities linked to ~30% higher 1-year mortality per region in hospitalized COVID-19 patients.
Why the study?
ECG abnormalities in COVID-19 patients have been widely reported, but data on their prognostic value after discharge are limited.
Do repolarization abnormalities on admission predict 1-year all-cause mortality in hospitalized COVID-19 patients?
Cohort (n=420)
No
Do repolarization abnormalities on admission predict 1-year all-cause mortality in hospitalized COVID-19 patients?
The presence and extent of repolarization abnormalities on admission, as well as new abnormalities post-discharge, are independent predictors of mortality in hospitalized COVID-19 patients.
Answers are grounded in this paper and cite their sources.
May support ECG risk stratification in hospitalized COVID-19; hypothesis-generating pending prospective validation before practice change.
BACKGROUND: ECG abnormalities in COVID-19 have been widely reported, however data after discharge is limited. The aim was to describe ECG abnormalities on admission and following recovery of COVID-19, and their associated mortality. METHODS: All patients hospitalized in a tertiary care hospital between March 7th and July 1st 2020 with COVID-19 were included in a retrospective registry. The first ECG on admission was collected, together with an ECG after hospital discharge in the absence of acute pathology. Automated measures and clinical ECG interpretations were collected. Multivariate Cox regression analysis was performed to predict 1-year all-cause mortality. RESULTS: In total 420 patients were included, of which 83 patients (19.8%) died during the 1-year follow-up period. Repolarization abnormalities were present in 189 patients (45.0%). The extent of repolarization abnormalities was an independent predictor of 1-year all-cause mortality (HR per region 1.30, 95%CI 1.04-1.64) together with age (/year HR 1.06, 95%CI 1.04-1.08), heart rate (/bpm HR 1.02, 95%CI 1.01-1.03), neurological disorders (HR 2.41, 95%CI 1.47-3.93), active cancer (HR 2.75, 95%CI 1.57-4.82), CRP (per 10 mg/L HR 1.05, 95%CI 1.02-1.08) and eGFR (per 10 mg/L HR 0.90, 95%CI 0.83-0.98).In 245 patients (68.1%) an ECG post discharge was available. New repolarization abnormalities were more frequent in patients who died after discharge (4.7% versus 41.7%, p < 0.001) and 8 (3.3%) had new ventricular conduction defects, none of whom died during follow-up. CONCLUSIONS: The presence and extent of repolarization abnormalities predicted outcome in patients with COVID-19. New repolarization abnormalities after discharge were associated with post-discharge mortality.
No takes yet. Share an insight, caveat, or question.
Vandenberk et al. (2021) conducted a cohort in COVID-19 (n=420). Extent of repolarization abnormalities on admission vs. Absence or lesser extent of repolarization abnormalities was evaluated on 1-year all-cause mortality (HR 1.30, 95% CI 1.04-1.64). The extent of repolarization abnormalities on admission independently predicted 1-year all-cause mortality in patients hospitalized with COVID-19.
Synapse has enriched 10 related papers. Consider them for comparative context: